Role of aquaporin 1 signalling in cancer development and progression

Files

hdl_125708.pdf (534.57 KB)
  (Published version)

Date

2017

Authors

Tomita, Y.
Dorward, H.
Yool, A.J.
Smith, E.
Townsend, A.R.
Price, T.J.
Hardingham, J.E.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

International Journal of Molecular Sciences, 2017; 18(2):299-1-299-17

Statement of Responsibility

Yoko Tomita, Hilary Dorward, Andrea J. Yool, Eric Smith, Amanda R. Townsend, Timothy J. Price and Jennifer E. Hardingham

Conference Name

Abstract

Cancer is a major health burden worldwide. Despite the advances in our understanding of its pathogenesis and continued improvement in cancer management and outcomes, there remains a strong clinical demand for more accurate and reliable biomarkers of metastatic progression and novel therapeutic targets to abrogate angiogenesis and tumour progression. Aquaporin 1 (AQP1) is a small hydrophobic integral transmembrane protein with a predominant role in trans-cellular water transport. Recently, over-expression of AQP1 has been associated with many types of cancer as a distinctive clinical prognostic factor. This has prompted researchers to evaluate the link between AQP1 and cancer biological functions. Available literature implicates the role of AQP1 in tumour cell migration, invasion and angiogenesis. This article reviews the current understanding of AQP1-facilitated tumour development and progression with a focus on regulatory mechanisms and downstream signalling pathways.

School/Discipline

Dissertation Note

Provenance

Description

Published: 29 January 2017

Access Status

Rights

© 2017 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

License

Grant ID

Call number

Persistent link to this record